List of works - Maria Diez-Campelo

A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.

scientific article published on 4 February 2017

Azacytidine for the treatment of myelodysplastic syndromes in the elderly.

scientific article published on 9 March 2011

Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease

scientific article published on 01 September 2008

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.

scientific article

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.

scientific article

Chronic graft-versus-host disease: Pathogenesis and clinical management.

scientific article

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

scientific article published on 01 October 2008

Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.

scientific article published on 20 May 2009

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

scientific article published on 5 July 2016

Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

scientific article published on 06 June 2019

Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena

scientific article published on 01 April 2005

Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications

scientific article published on 18 December 2014

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

scientific article

Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells.

scientific article published in January 2009

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

scientific article published on 20 March 2003

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

scientific article published on 01 August 2005

Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant

scientific article published on 01 April 2010

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

scientific article

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

scientific article

Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients.

scientific article published on 2 February 2016

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies

scientific article published on 01 March 2009

Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?

scientific article

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study

scientific article

Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive the

scientific article published on 01 October 2008

Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine

scientific article published on 06 June 2013

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.

scientific article published on 5 September 2015

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.

scientific article published on 25 April 2013

Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome

scientific article published on 10 February 2014

Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.

scientific article

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

article

Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing

scientific article published on 7 October 2013

The role of immature platelet fraction in acute coronary syndrome

scientific article published on 13 November 2009

Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis

scientific article

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population.

scientific article published on 8 June 2009

Uptake and delivery of antigens by mesenchymal stromal cells.

scientific article published on 21 March 2013

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study

scientific article published on 20 May 2015

List of works by Maria Diez-Campelo

A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.

Azacytidine for the treatment of myelodysplastic syndromes in the elderly.

Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.

Chronic graft-versus-host disease: Pathogenesis and clinical management.

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena

Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells.

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients.

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies

Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study

Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive the

Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.

Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome

Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing

The role of immature platelet fraction in acute coronary syndrome

Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population.

Uptake and delivery of antigens by mesenchymal stromal cells.

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study